ATE136467T1 - Biologisches präparat und seine verwendung - Google Patents

Biologisches präparat und seine verwendung

Info

Publication number
ATE136467T1
ATE136467T1 AT90912314T AT90912314T ATE136467T1 AT E136467 T1 ATE136467 T1 AT E136467T1 AT 90912314 T AT90912314 T AT 90912314T AT 90912314 T AT90912314 T AT 90912314T AT E136467 T1 ATE136467 T1 AT E136467T1
Authority
AT
Austria
Prior art keywords
biological preparation
antigenic
relates
material derived
treatment against
Prior art date
Application number
AT90912314T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE136467T1 publication Critical patent/ATE136467T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Thin Film Transistor (AREA)
  • Recrystallisation Techniques (AREA)
  • Steroid Compounds (AREA)
AT90912314T 1989-07-28 1990-07-27 Biologisches präparat und seine verwendung ATE136467T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917256A GB8917256D0 (en) 1989-07-28 1989-07-28 Biological preparation and its use

Publications (1)

Publication Number Publication Date
ATE136467T1 true ATE136467T1 (de) 1996-04-15

Family

ID=10660759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912314T ATE136467T1 (de) 1989-07-28 1990-07-27 Biologisches präparat und seine verwendung

Country Status (13)

Country Link
EP (1) EP0484438B1 (de)
JP (1) JPH05500803A (de)
AT (1) ATE136467T1 (de)
AU (1) AU644376B2 (de)
CA (1) CA2064029C (de)
DE (1) DE69026506T2 (de)
DK (1) DK0484438T3 (de)
ES (1) ES2088431T3 (de)
FI (1) FI920356A0 (de)
GB (1) GB8917256D0 (de)
NO (1) NO920331L (de)
WO (1) WO1991001751A1 (de)
ZA (1) ZA905927B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
CA2095855C (en) * 1990-11-08 2003-04-29 Graham A.W. Rook Mycobacterium as adjuvant for antigens
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
EA200300784A1 (ru) * 2001-01-17 2004-10-28 Бакулиш Мафатлал Хамар Способ лечения заболевания/инфекции вирусом иммунодефицита человека (вич)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen

Also Published As

Publication number Publication date
NO920331D0 (no) 1992-01-24
FI920356A7 (fi) 1992-01-27
WO1991001751A1 (en) 1991-02-21
GB8917256D0 (en) 1989-09-13
CA2064029C (en) 1998-12-29
JPH05500803A (ja) 1993-02-18
EP0484438B1 (de) 1996-04-10
AU644376B2 (en) 1993-12-09
CA2064029A1 (en) 1991-01-29
AU6188390A (en) 1991-03-11
NO920331L (no) 1992-01-24
DE69026506T2 (de) 1996-09-12
DK0484438T3 (da) 1996-06-10
ES2088431T3 (es) 1996-08-16
EP0484438A1 (de) 1992-05-13
DE69026506D1 (de) 1996-05-15
FI920356A0 (fi) 1992-01-27
ZA905927B (en) 1991-05-29

Similar Documents

Publication Publication Date Title
ATE132755T1 (de) Mycobacterium vaccae in der behandlung von uveitis
DE69026506D1 (de) Biologisches präparat und seine verwendung
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
DE3886254D1 (de) Apparat zur Behandlung von biologischen Proben und Behandlungsmethoden mit dem Apparat.
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
AT380202B (de) Material zur herstellung von artikeln zur abstuetzung des kopfes oder von gliedmassen des menschen oder von tieren, sowie aus diesem material hergestellte artikel
DE69004037D1 (de) Apparat zur Wärmebehandlung von kontaminiertem, stückigem Material.
CA2186851A1 (en) Use of mycobacteria for the treatment of tumours
ATE151641T1 (de) Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
DK0427462T3 (da) Fremgangsmåde
JPS5411229A (en) Vaccine for treating bacillus coli disease and use thereof
DE68908404D1 (de) Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens.
ATE75727T1 (de) Noremopamil, seine herstellung und verwendung.
ES1005800Y (es) Dispositivo manual mejorado reactivador de la circulacion cutanea por friccion
EP0266563A3 (en) Use of 1-benzyl-amino-alkyl-pyrrolidinones as antidepressants
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
DE3770945D1 (de) Vorrichtung zur behandlung von luftschiffen.
DE3887137D1 (de) Mittel zur prophylaxe und behandlung einer pankreatischen erkrannkung oder dergleichen.
ATE92761T1 (de) Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee